A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects with Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency

Project: Research project

Project Details

StatusFinished
Effective start/end date12/8/15 → 8/31/16

Funding

  • Anthera Pharmaceuticals, Inc.